Exiqon Licenses LNA Technology to Becton Dickinson

The deal marks the first in which the LNA technology will be applied to the development of FDA-cleared diagnostics, according to Exiqon.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.